Apr 02, 2020
AMRA Medical and Fulcrum Therapeutics Develop MRI Method for Multi-site Neuromuscular Clinical Trials
Mar 31, 2020
Muscular Dystrophy Association to Host MDA Frontline COVID-19 Response with Dr. Barry Byrne, a Facebook Live Q&A on Protecting Neuromuscular Disease Community in Midst of COVID-19 Pandemic
Dec 13, 2019
MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
Aug 27, 2019
Burn Boot Camp Raises $523,690 Through Second Annual National "Be Their Muscle" Fundraiser Event
Jul 16, 2019
MDA Awards Venture Philanthropy Funding to Dr. Rachelle Crosbie to Develop a Novel Membrane-Stabilizing Drug for Duchenne Muscular Dystrophy
May 06, 2019
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
Mar 26, 2019
Muscular Dystrophy Association Bridges Clinical and Academic Neuromuscular Research for the First Time at Annual Meeting
Feb 07, 2019
GPM Investments, LLC Raises More Than $244,000 to Help Kids and Adults with Muscular Dystrophy, ALS and Related Neuromuscular Diseases via Holiday Pinups
Jan 18, 2019
Global Myasthenia Gravis Market 2017-2018 & 2026: Increase in Occurrence of Autoimmune Disorders and Strong Pipeline Propelling Market Growth
Jan 15, 2019
MDA Awards Venture Philanthropy Grant to AcuraStem to Develop Novel Treatment for ALS
Nov 28, 2018
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
Sep 06, 2018
Flagship's Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine
Apr 24, 2018
Prime Therapeutics Finds Drug's Additional Use for Myasthenia Gravis May Significantly Impact Trend
Feb 20, 2018
Researchers Demonstrate Therapeutic Antibodies Stabilize Nerve-Muscle Synapses in a Mouse Model of ALS
Dec 14, 2017
NeuX Technologies and Muscle Activation Technique Execute Letter of Intent for a Strategic Alliance to Develop Integrated Solutions to Treat and Prevent Musculoskeletal Conditions and Chronic Pain
Dec 05, 2017
Myasthenia Gravis Market Value to Reach US$2,313.1 Million by the End of 2025: Transparency Market Research
Aug 08, 2017
Myasthenia Gravis Market Analysis: Global Size, Share, Trends, Growth Drivers, Industry Demand, Competitive Landscape and Forecasts to 2021- MarketReportsOnline